5 obscure ASX stocks that have crashed because of the Coronavirus

‘Risk comes from not knowing what you're doing,’ Warren Buffet once said.

The pledge

About two weeks ago, we ran a story titled: Why 5 tiny ASX stocks have soared because of the Coronavirus.

In it we briefly profiled the share price performance (for the month ending 3 March) of five obscure ASX-listed companies that had or did stand to benefit from the Coronavirus (COVID-19) crisis.

There was Zoono, an antimicrobial stock that had risen 136%; Uscom a medical device company that was up a staggering 186%; Aeris Environmental, that like Zoono produced disinfectants and had gained 55%; Biotron a promising viral drugs company that was up 38%; and finally, Eagle Health, a sort of logistics play that was going to help Zoono with Chinese distribution, also up 54%.

Mind you, since we ran that story, the Coronavirus crisis has only escalated: Across the globe there are now over 169,000 reported cases of the virus and over 6,500 deaths as a direct result of it.

In response to the hard-to-quantify economic impact of all this, equity markets themselves have been performing in an understandably whacky fashion, as broader markets swing between desolate pessimist and jubilant optimism.

For example, the ASX 200 recorded its largest ever intra-day shock today, tumbling 537 points or 9.7% by the close; and even though the US Federal Reserve announced on Sunday that they’d be cutting interest rates to near zero, US futures markets still crumbled, with DOW futures down over 1,000 points in response.

Benjamin Graham, the legendary value investor, described these types of market extremes in his famous work, the Intelligent Investor. Here Mr Graham highlighted the inherently volatile nature of the market, through his now famous ‘Mr Market’ parable, saying:

‘At times he [Mr Market] feels euphoric and can see only the favourable factors affecting the business.’

But at other times, Graham warned:

‘He is depressed and can see nothing but trouble ahead for both the business and the world.

How to trade the ASX 200 Index

Do you think markets will keep falling or are well close to a bottom? You can use CFDs to trade the ASX 200 Index LONG or SHORT through IG’s world-class trading platform now.

For example, to buy (long) or sell (short) the ASX 200 Index, follow these easy steps:

  • Create an IG Trading Account or log in to your existing account
  • Enter ‘Australia 200’ or 'ASX 200' in the search bar and select it
  • Choose your position size
  • Click on ‘buy’ or ‘sell’ in the deal ticket
  • Confirm the trade

The turn: Zoono, Uscom, Biotron share prices and others

Getting back to our original point, in our first story on those five obscure stocks we asked: ‘Are these stocks all hype or are they the real deal?’ That is, was the market pricing those equities fairly and efficiently; or had they ran well ahead of their fundamentals.

Well, it seems as if the market (Mr Market) has gifted us with a relatively definitive answer to that question: with those stocks’ frothy gains turning to modest losses in the last week.

According to the ASX, in the last five days (now ending 16 March) Zoono has seen its share price fall 12.50%, Uscom has dropped 16.07%, Aeris has slid 21.36%, Biotron is now down 13.04% and finally, Eagle Health has seen its share price come off the most significant of the bunch, falling 23.08%.

These kind of reversals illuminate the inherent risk of equity investing – particularly when you are playing at the speculative end of the market.

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

Please see important Research Disclaimer.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices
liveprices.javascriptrequired
liveprices.javascriptrequired

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

liveprices.javascriptrequired

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Monday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.